Global Spatial Genomics and Transcriptomics Market
March 7, 2023
BCC Research
157
PDF
Global Spatial Genomics and Transcriptomics Market
Abstract Report Scope:
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes:
- 34 data tables and 30 additional tables - An overview of the global spatial genomics and transcriptomics market - Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027 - Estimation of the market size and highlights of the market potential by technology, end user, and application - Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry - Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth - Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market - Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues - Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Content Table of Contents
Chapter 1 Introduction 1.1 Study Goals and Objectives 1.2 Reasons for Doing this Study 1.3 Scope of Report 1.4 Information Sources 1.5 Methodology 1.6 Geographic Breakdown 1.7 Analyst's Credentials 1.8 BCC Custom Research 1.9 Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Market Overview 3.1 Spatial Genomics and Transcriptomics 3.1.1 Spatial Genomics 3.1.2 Spatial Transcriptomics 3.2 Spatial Transcriptomics Technologies 3.2.1 Fusion of Multiple Technologies 3.2.2 Spatial Genomics and Transcriptomics Provides Balance 3.3 Understanding Spatial Biology 3.4 Importance of Spatial Biology 3.5 Spatial Sequencing 3.6 Spatial Biology of Cancer Evolution 3.7 Innovation in Medical and Healthcare Products 3.8 Current Trends 3.8.1 Enhanced Cybersecurity 3.8.2 Internet of Medical Things 3.8.3 Medical Robots 3.8.4 Three-Dimensionally Printed Objects 3.8.5 Device Connectivity 3.8.6 Implications for Health Systems 3.9 Regulations and Legislation 3.9.1 Europe 3.9.2 U.S. 3.9.3 Japan Chapter 4 Market Dynamics 4.1 Drivers 4.1.1 New Discoveries in Biological Sciences 4.1.2 Increasing Use of Bioinformatics Analytical Software 4.1.3 Antibody-Based Drug Discovery and Development 4.1.4 Developed and Increasing Research Areas 4.1.5 Application-Focused Technology Platforms 4.1.6 Strengthen Use and Adoption of Consumables 4.1.7 Increase in Infectious and Chronic Diseases 4.1.8 Relationships among Biopharma Firms, Research Institutions and Medical Centers 4.2 Restraints 4.2.1 Labor-Intensive Technology and Products 4.3 Opportunities 4.3.1 Human Genome Project Development 4.3.2 Coming Revolution of Precision Medicine 4.4 Strategies 4.4.1 Trends Chapter 5 Impact of the COVID-19 Pandemic 5.1 Impact of COVID-19 on Pharmaceutical and Biotech Industries 5.2 Short-Term Impact 5.2.1 Change in Demand 5.2.2 Shift of Communication and Promotions to Remote Interactions 5.2.3 Changes in R&D 5.3 Long-Term Impact 5.3.1 Delayed Approvals for Non-COVID-Related Pharmaceutical and Biotech Products 5.3.2 Self-Sufficiency in the Pharma and Biotech Industries 5.3.3 Pharmaceutical Industry Growth Slowdown 5.3.4 Changes in Consumption Trends in Health-Related Products 5.3.5 Potential Impact of COVID-19 on Genomic Study Chapter 6 Business Model and Innovation 6.1 Business Model Innovation Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market 7.1 Overview 7.2 Spatial Genomics 7.2.1 Market Outlook 7.3 Spatial Transcriptomics 7.3.1 Market Outlook Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product 8.1 Overview 8.2 Market for Spatial Genomics and Transcriptomics, by Product 8.3 Market Outlook 8.3.1 Consumables 8.3.2 Instruments 8.3.3 Software Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application 9.1 Overview 9.2 Spatial Genomics and Transcriptomics Market by Application 9.3 Market Outlook 9.3.1 Clinical and Translational Research 9.3.2 Drug Discovery and Development Chapter 10 Global Spatial Genomics and Transcriptomics Market by End User 10.1 Overview 10.2 Market for Spatial Genomics and Transcriptomics by End User 10.3 Market Outlook 10.3.1 Academic and Research Institutes 10.3.2 Contract Research Organizations 10.3.3 Pharmaceutical and Biotechnology Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region 11.1 North America 11.1.1 Market Outlook 11.2 Europe 11.2.1 Market Outlook 11.3 Asia-Pacific 11.3.1 Market Outlook 11.4 Rest of the World 11.4.1 Market Outlook Chapter 12 Competitive Landscape Chapter 13 Company Profiles 10X GENOMICS ADVANCED CELL DIAGNOSTICS INC. AKOYA BIOSCIENCES INC. BRUKER CORP. DOVETAIL GENOMICS (CANTATA BIO) ILLUMINA IONPATH INC. LUNAPHORE TECHNOLOGIES S.A. NANOSTRING TECHNOLOGIES RARECYTE INC. STANDARD BIOTOOLS INC. VIZGEN INC. Other Companies
List of Tables Summary Table : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 1 : Differences Between Single-Cell RNA-Seq and RNA-Seq Table 2 : Class I and II Exempt Devices Table 3 : Akoya’s Relationship with Universities and Organizations Table 4 : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 5 : Global Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 6 : Global Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 7 : Global Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 8 : Global Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 9 : Global Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 10 : North American Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 11 : North American Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 12 : North American Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 13 : North American Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 14 : North American Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 15 : North American Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 16 : North American Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 17 : European Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 18 : European Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 19 : European Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 20 : European Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 21 : European Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 22 : European Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 23 : European Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 24 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 25 : Asia-Pacific Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 26 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 27 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 28 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 29 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 30 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 31 : RoW Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 32 : RoW Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 33 : RoW Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 34 : RoW Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 35 : RoW Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 36 : RoW Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 37 : RoW Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 38 : Recent Company News, 2022 Table 39 : 10xGenomics: Product Portfolio Table 40 : 10xGenomics: Recent Developments, 2020-2022 Table 41 : Advanced Cell Diagnostics Inc.: Product Portfolio Table 42 : Advanced Cell Diagnostics Inc.: Recent Developments, 2019-2023 Table 43 : Akoya Biosciences Inc.: Product Portfolio Table 44 : Akoya Biosciences Inc.: Recent Developments, 2020-2022 Table 45 : Bruker: Product Portfolio Table 46 : Bruker: Recent Developments, 2021-2023 Table 47 : Dovetail Genomics: Product Portfolio Table 48 : Dovetail Genomics: Recent Developments, 2019-2022 Table 49 : Illumina: Product Portfolio Table 50 : Illumina: Recent Developments, 2020-2023 Table 51 : Ionpath Inc.: Product Portfolio Table 52 : Ionpath Inc.: Recent Developments, 2020-2022 Table 53 : Lunaphore: Product Portfolio Table 54 : Lunaphore: Recent Developments, 2022 Table 55 : NanoString: Product Portfolio Table 56 : NanoString: Recent Developments, 2020-2022 Table 57 : RareCyte: Product Portfolio Table 58 : RareCyte: Recent Developments, 2021 and 2022 Table 59 : Standard BioTools Inc.: Product Portfolio Table 60 : Standard BioTools Inc.: Recent Developments, 2019-2022 Table 61 : Vizgen: Product Portfolio Table 62 : Vizgen: Recent Developments, 2021-2023 Table 63 : Other Spatial Genomics and Transcriptomics Startups
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes:
- 34 data tables and 30 additional tables - An overview of the global spatial genomics and transcriptomics market - Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027 - Estimation of the market size and highlights of the market potential by technology, end user, and application - Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry - Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth - Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market - Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues - Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Table of Contents
Chapter 1 Introduction 1.1 Study Goals and Objectives 1.2 Reasons for Doing this Study 1.3 Scope of Report 1.4 Information Sources 1.5 Methodology 1.6 Geographic Breakdown 1.7 Analyst's Credentials 1.8 BCC Custom Research 1.9 Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Market Overview 3.1 Spatial Genomics and Transcriptomics 3.1.1 Spatial Genomics 3.1.2 Spatial Transcriptomics 3.2 Spatial Transcriptomics Technologies 3.2.1 Fusion of Multiple Technologies 3.2.2 Spatial Genomics and Transcriptomics Provides Balance 3.3 Understanding Spatial Biology 3.4 Importance of Spatial Biology 3.5 Spatial Sequencing 3.6 Spatial Biology of Cancer Evolution 3.7 Innovation in Medical and Healthcare Products 3.8 Current Trends 3.8.1 Enhanced Cybersecurity 3.8.2 Internet of Medical Things 3.8.3 Medical Robots 3.8.4 Three-Dimensionally Printed Objects 3.8.5 Device Connectivity 3.8.6 Implications for Health Systems 3.9 Regulations and Legislation 3.9.1 Europe 3.9.2 U.S. 3.9.3 Japan Chapter 4 Market Dynamics 4.1 Drivers 4.1.1 New Discoveries in Biological Sciences 4.1.2 Increasing Use of Bioinformatics Analytical Software 4.1.3 Antibody-Based Drug Discovery and Development 4.1.4 Developed and Increasing Research Areas 4.1.5 Application-Focused Technology Platforms 4.1.6 Strengthen Use and Adoption of Consumables 4.1.7 Increase in Infectious and Chronic Diseases 4.1.8 Relationships among Biopharma Firms, Research Institutions and Medical Centers 4.2 Restraints 4.2.1 Labor-Intensive Technology and Products 4.3 Opportunities 4.3.1 Human Genome Project Development 4.3.2 Coming Revolution of Precision Medicine 4.4 Strategies 4.4.1 Trends Chapter 5 Impact of the COVID-19 Pandemic 5.1 Impact of COVID-19 on Pharmaceutical and Biotech Industries 5.2 Short-Term Impact 5.2.1 Change in Demand 5.2.2 Shift of Communication and Promotions to Remote Interactions 5.2.3 Changes in R&D 5.3 Long-Term Impact 5.3.1 Delayed Approvals for Non-COVID-Related Pharmaceutical and Biotech Products 5.3.2 Self-Sufficiency in the Pharma and Biotech Industries 5.3.3 Pharmaceutical Industry Growth Slowdown 5.3.4 Changes in Consumption Trends in Health-Related Products 5.3.5 Potential Impact of COVID-19 on Genomic Study Chapter 6 Business Model and Innovation 6.1 Business Model Innovation Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market 7.1 Overview 7.2 Spatial Genomics 7.2.1 Market Outlook 7.3 Spatial Transcriptomics 7.3.1 Market Outlook Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product 8.1 Overview 8.2 Market for Spatial Genomics and Transcriptomics, by Product 8.3 Market Outlook 8.3.1 Consumables 8.3.2 Instruments 8.3.3 Software Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application 9.1 Overview 9.2 Spatial Genomics and Transcriptomics Market by Application 9.3 Market Outlook 9.3.1 Clinical and Translational Research 9.3.2 Drug Discovery and Development Chapter 10 Global Spatial Genomics and Transcriptomics Market by End User 10.1 Overview 10.2 Market for Spatial Genomics and Transcriptomics by End User 10.3 Market Outlook 10.3.1 Academic and Research Institutes 10.3.2 Contract Research Organizations 10.3.3 Pharmaceutical and Biotechnology Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region 11.1 North America 11.1.1 Market Outlook 11.2 Europe 11.2.1 Market Outlook 11.3 Asia-Pacific 11.3.1 Market Outlook 11.4 Rest of the World 11.4.1 Market Outlook Chapter 12 Competitive Landscape Chapter 13 Company Profiles 10X GENOMICS ADVANCED CELL DIAGNOSTICS INC. AKOYA BIOSCIENCES INC. BRUKER CORP. DOVETAIL GENOMICS (CANTATA BIO) ILLUMINA IONPATH INC. LUNAPHORE TECHNOLOGIES S.A. NANOSTRING TECHNOLOGIES RARECYTE INC. STANDARD BIOTOOLS INC. VIZGEN INC. Other Companies
List of Tables Summary Table : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 1 : Differences Between Single-Cell RNA-Seq and RNA-Seq Table 2 : Class I and II Exempt Devices Table 3 : Akoya’s Relationship with Universities and Organizations Table 4 : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 5 : Global Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 6 : Global Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 7 : Global Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 8 : Global Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 9 : Global Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 10 : North American Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 11 : North American Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 12 : North American Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 13 : North American Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 14 : North American Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 15 : North American Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 16 : North American Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 17 : European Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 18 : European Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 19 : European Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 20 : European Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 21 : European Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 22 : European Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 23 : European Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 24 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 25 : Asia-Pacific Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 26 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 27 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 28 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 29 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 30 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 31 : RoW Spatial Genomics and Transcriptomics Market, by Technology, Through 2027 Table 32 : RoW Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027 Table 33 : RoW Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027 Table 34 : RoW Spatial Genomics and Transcriptomics Market, by Product, Through 2027 Table 35 : RoW Spatial Genomics and Transcriptomics Market, by Application, Through 2027 Table 36 : RoW Spatial Genomics and Transcriptomics Market, by End User, Through 2027 Table 37 : RoW Spatial Genomics and Transcriptomics Market, by Country, Through 2027 Table 38 : Recent Company News, 2022 Table 39 : 10xGenomics: Product Portfolio Table 40 : 10xGenomics: Recent Developments, 2020-2022 Table 41 : Advanced Cell Diagnostics Inc.: Product Portfolio Table 42 : Advanced Cell Diagnostics Inc.: Recent Developments, 2019-2023 Table 43 : Akoya Biosciences Inc.: Product Portfolio Table 44 : Akoya Biosciences Inc.: Recent Developments, 2020-2022 Table 45 : Bruker: Product Portfolio Table 46 : Bruker: Recent Developments, 2021-2023 Table 47 : Dovetail Genomics: Product Portfolio Table 48 : Dovetail Genomics: Recent Developments, 2019-2022 Table 49 : Illumina: Product Portfolio Table 50 : Illumina: Recent Developments, 2020-2023 Table 51 : Ionpath Inc.: Product Portfolio Table 52 : Ionpath Inc.: Recent Developments, 2020-2022 Table 53 : Lunaphore: Product Portfolio Table 54 : Lunaphore: Recent Developments, 2022 Table 55 : NanoString: Product Portfolio Table 56 : NanoString: Recent Developments, 2020-2022 Table 57 : RareCyte: Product Portfolio Table 58 : RareCyte: Recent Developments, 2021 and 2022 Table 59 : Standard BioTools Inc.: Product Portfolio Table 60 : Standard BioTools Inc.: Recent Developments, 2019-2022 Table 61 : Vizgen: Product Portfolio Table 62 : Vizgen: Recent Developments, 2021-2023 Table 63 : Other Spatial Genomics and Transcriptomics Startups